1. Home
  2. Laboratory Improvement
  3. Proficiency Testing
  4. New Surveys and Anatomic Pathology Education Programs

New 2024 Surveys and Anatomic Pathology Education Programs

See what's new before you renew your PT/EQA for 2024

As laboratory medicine changes, the CAP provides a comprehensive range of proficiency testing/external quality assessment (PT/EQA) programs to support your continued mission to deliver accurate and reliable test results to the patients you serve.


  • Review online whole slide images of immunohistochemistry stains for breast cancer predictive markers HER2 and ER (HERI).
  • Perform PT/EQA for sexually transmitted infections using molecular multiplex methodology (STIM).
  • Conduct PT/EQA for H. pylori bacteria, which is associated with peptic ulcer disease (HPBT).
  • Compare cardiac marker performance across instruments including high-sensitivity troponin I and T, CK-MB, and myoglobin (HCRQ).

View all our new programs and decide which ones are right for you.

New PT/EQA Programs for 2023/2024

  • Open all Toggle
  • Close all Toggle
  • Interpretation of immunohistochemistry stains for HER2 and ER (HERI)
  • Preparation of histologic slides in all anatomic pathology laboratories (HQTAR and HQCLB)
  • Critical care blood gas measurement with or without hematocrit and/or hemoglobin (AQ, AQH) and for laboratories using an i-STAT instrument (AQIS)
  • Challenges that mimic patient-related factor deficiencies (ECF)
  • Detection of H. pylori bacteria, which is associated with peptic ulcer disease (HPBT)
  • Quantitation of acylcarnitine related to inherited metabolic disorders (BGL4)
  • Prognostic marker using FISH to identify the ALK rearrangement in lung (CYALK)
  • Next-generation sequencing bioinformatics platform-agnostic in silico PT and validated materials (NGSB4 and NGSB5)
  • Cost-effective option for blood cell identification (BCPV)
  • Complete blood count and differential as well as nucleated red blood cell (nRBC) parameter (FH17)
  • Multiplex PCR panel for sexually transmitted infection (STIM)
  • Monkeypox virus proficiency testing for US laboratories (MPOX)
  • Proficiency testing for laboratories that only perform non-waived testing for SARS-CoV-2 (COVM, CVAG)
  • Carbapenemase detection methods to ensure testing quality and staff competency (CRE)
  • Automated direct antiglobulin testing (ADAT)

New Quality Improvement Programs for 2023/2024

  • Open all Toggle
  • Close all Toggle
  • Calibration verification and linearity for cystatin C to monitor kidney function (LN49)
  • Calibration verification and linearity for high-sensitivity Troponin I to monitor cardiac function (LN48)

Monitor performance and assess comparability across multiple instruments for:

  • High sensitivity cardiac markers (HCRQ)
  • Critical care blood gas with or without hematocrit (AQQ, AQHQ)
  • Critical care blood gas using an i-STAT instrument (AQSQ)
  • Respiratory viruses (ID3Q)

Aid quality improvement efforts and assist with checklist requirements in your laboratory.

  • Tools for monitoring rates and turnaround times to investigate and report suspected transfusion reactions (QP241)
  • Technical competency assessment of body fluid review for more participants (QPB25)

New Continuing Medical Education Programs

Advance skills with educational activities developed by physicians and doctoral scientists with expertise in pathology and laboratory medicine.

  • Discernment of potential discrepancies between biomarker testing modalities for individual (NMBA) and additional participant(s) (NMB1)

New CAP Publications for 2024

Stay current in diagnostic learning with our newest high-quality publications written and edited by recognized experts in pathology and laboratory medicine.

  • Disruptive Technologies in Clinical Medicine (PUB318)
         Frederick L. Kiechle, MD, PhD, FCAP